Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
- Code:
- 3403-v
- Name:
- Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
- [Myristoyl-PKCζ (113-125)/ζ-Pseudosubstrate Inhibitory Peptide (ZIP)]
- Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
- (Trifluoroacetate Form)
- (M.W. 1928.4) C90H154N30O17
- Myristoylated Cell Permeable PKCζ Pseudosubstrate Inhibitor
- main
- more information
- reference
main
- Purity:
- ≧95.0% (HPLC)
- Storage:
- -20 ℃
- Production:
- Synthetic Product
Solubility: H2O (1 mM)
more information
- Category:
- Peptide Tools
reference
- C. Laudanna, D. Mochly-Rosen, T. Liron, G. Constantin, and E.C. Butcher, J. Biol. Chem., 273, 30306 (1998). (Pharmacol.)
- S. Lim, J.W. Choi, H.S. Kim, Y.-H. Kim, K. Yea, K. Heo, J.H. Kim, S.-H. Kim, M. Song, J.I. Kim, S.H. Ryu, and P.-G. Suh, Life Sci., 82, 733 (2008). (Biochem.)
- T. Hirose, D. Satoh, H. Kurihara, C. Kusaka, H. Hirose, K. Akimoto, T. Matsusaka, I. Ichikawa, T. Noda, and S. Ohno, PLoS ONE, 4, e4194 (2009). (Pharmacol. & Histochem.)
- P.V. Migues, O. Hardt, D.C. Wu, K. Gamache, T.C. Sacktor, Y.T. Wang, and K. Nader, Nat. Neurosci., 13, 630 (2010). (Pharmacol.)
SDS: 他の製品を検索する
